Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Vistagen Therapeutics (VTGN) Common Equity (2009 - 2026)

Updated

Vistagen Therapeutics' Common Equity came in at $14.99 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 77.4% from $66.34 million a year earlier and down 38.8% from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) Common Equity (2009 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Vistagen Therapeutics' Common Equity was $35.52 million, down 49.5% from FY2025.

  • Common Equity carries a five-year compound annual growth rate of -17.3% (FY2021 to FY2026).
  • Going back by fiscal year, Common Equity was $70.39 million in FY2025 (-38.4%), $114.29 million in FY2024 (+846.1%), $12.08 million in FY2023 (-81.3%) and $64.72 million in FY2022 (-29.6%).
  • The fiscal Q2 2027 figure represents the lowest quarterly Common Equity since fiscal Q1 2024.
  • Year-over-year, Common Equity has declined for eight consecutive quarters, with an average decline of 46.0% over the last eight quarters.
  • The fastest year-over-year change in Common Equity over five years came in fiscal Q4 2024 (growth of 846.1%), and the weakest in fiscal Q1 2024 (a decline of 85.1%).
  • Business Quant data shows VTGN's Common Equity at $24.48 million (Q1 2027), $35.52 million (Q4 2026) and $50.92 million (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -159,093.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 40.27 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 81.53 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn -4.58 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 44.95 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 14.35 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 13.04 Bn
9 Gsk 193.54 Bn 176.38 Bn - 24.30 Bn
10 Vistagen Therapeutics 7.34 Mn -151.60 Mn - 14.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 14.99 Mn
Jun 30, 2026 24.48 Mn
Mar 31, 2026 35.52 Mn
Dec 31, 2025 50.92 Mn
Sep 30, 2025 66.34 Mn
Jun 30, 2025 56.77 Mn
Mar 31, 2025 70.39 Mn
Dec 31, 2024 81.12 Mn
Sep 30, 2024 92.97 Mn
Jun 30, 2024 104.80 Mn
Mar 31, 2024 114.29 Mn
Dec 31, 2023 123.29 Mn
Sep 30, 2023 35.65 Mn
Jun 30, 2023 6.85 Mn
Mar 31, 2023 12.08 Mn
Dec 31, 2022 20.67 Mn
Sep 30, 2022 29.61 Mn
Jun 30, 2022 46.05 Mn
Mar 31, 2022 64.72 Mn
Dec 31, 2021 79.98 Mn
API Access

Vistagen Therapeutics Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=VTGN&period=max&api_key=YOUR_API_KEY